Conflicting information has been published on changes of plasma protein binding in the elderly
I received my order quickly and the product is exactly as promised
At a glance Drug / evolocumab (Repatha), a PCSK9-inhibitor biologic antibody Supplement / glutathione (oral, liposomal, or IV forms) Known interaction / none documented in published literature or FDA label Interaction type / not applicable, no shared metabolic pathway identified Evolocumab clearance / proteolytic catabolism, not CYP450 or GSH-dependent Glutathione CYP effect / negligible at typical oral doses (250 to 1,000 mg/day) LDL-C reduction with evolocumab / up to 59% vs
Formulated with Glutathione, Vitamin C, and essential nutrients, it works from within to reduce pigmentation, improve skin tone, and protect against oxidative damage
Age alone is not a contraindication
Many users find this formula works well on an empty stomach, which can speed absorption